A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression

The American Journal of Psychiatry
Brendon BinnemanThomas Stiger

Abstract

The corticotropin-releasing hormone (CRH) system is implicated in the pathogenesis of several psychiatric disorders, including major depressive disorder. This study was designed to evaluate the safety and efficacy of CP-316,311, a selective nonpeptide antagonist of corticotropin-releasing hormone type 1 (CRH(1)) receptors, in the treatment of recurrent major depressive disorder. Of a total of 167 patients with recurrent major depression who were screened, 123 were randomly assigned to receive 400 mg of CP-316,311 twice daily, or 100 mg of sertraline daily, or placebo in a 6-week fixed-dose, double-blind, double-dummy, parallel-group, placebo- and sertraline-controlled trial. The primary efficacy analysis compared the change in score from baseline to endpoint on the 17-item Hamilton Depression Rating Scale (HAM-D) between the CP-316,311 and placebo groups. A group sequential design was used to support early trial termination based on efficacy or futility at a planned interim analysis. The evaluable data set for the interim analysis included 28 patients in the CP-316,311 group, 31 patients in the placebo group, and 30 patients in the sertraline group. In the interim analysis, the change from baseline in the HAM-D score at the fin...Continue Reading

Citations

Sep 16, 2010·Der Nervenarzt·F Holsboer
Sep 11, 2012·Psychopharmacology·Georgina Valeria Fernández MacedoSilvia Wikinski
Jul 21, 2009·Current Gastroenterology Reports·Yvette TachéAndreas Stengel
Nov 5, 2008·Current Psychiatry Reports·Paul E Holtzheimer, Charles B Nemeroff
Nov 12, 2013·Neuropeptides·Viktória Kormos, Balázs Gaszner
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Mark J Millan
Dec 17, 2009·Molecular Psychiatry·E B Binder, C B Nemeroff
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dimitri E GrigoriadisJohn A Williams
Oct 17, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Oliver J BoschLarry J Young
Oct 10, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cedomir TodorovicJoachim Spiess
Jun 2, 2009·Nature Reviews. Drug Discovery·George F KoobBarbara J Mason
Jun 26, 2010·Nature Reviews. Drug Discovery·Christian de BodinatMark J Millan
May 19, 2012·Nature Reviews. Drug Discovery·Guy Griebel, Florian Holsboer
Oct 21, 2011·Nature Reviews. Neuroscience·Markus HeiligCharles P O'Brien
Mar 23, 2010·International Clinical Psychopharmacology·Giorgio Racagni, Maurizio Popoli
Jul 7, 2009·Annual Review of Psychology·Florian Holsboer, Marcus Ising
Feb 4, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Marije aan het RotDennis S Charney
Aug 30, 2013·BioMed Research International·Gianluca SerafiniPaolo Girardi
Dec 4, 2013·Expert Opinion on Therapeutic Targets·Kanwaljit Chopra, Vipin Arora
Nov 2, 2013·Expert Review of Neurotherapeutics·Richard WeislerMichael Bauer
Jul 11, 2009·Expert Review of Neurotherapeutics·Cornelius SchüleRainer Rupprecht
May 22, 2010·Expert Opinion on Emerging Drugs·Marsal SanchesJair C Soares
May 21, 2009·Expert Opinion on Emerging Drugs·Dewleen G BakerVictoria B Risbrough
Mar 15, 2011·Expert Opinion on Investigational Drugs·Marcelo Paez-PeredaFlorian Holsboer
Jul 30, 2009·Expert Opinion on Emerging Drugs·Sidney H Kennedy, Sakina J Rizvi
Apr 26, 2012·Expert Opinion on Emerging Drugs·Sakina J Rizvi, Sidney H Kennedy
Jan 3, 2016·Progress in Neurobiology·Rodrigo Machado-VieiraCarlos A Zarate
Jun 12, 2012·Bioorganic & Medicinal Chemistry Letters·Kunitoshi TakedaMasahiro Yonaga

❮ Previous
Next ❯

Software Mentioned

East

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.